GENSIA'S GENESA SYSTEM FOR STRESS TESTING "APPEARS EQUIVALENT TO EXERCISE" FOR USE IN DIAGNOSIS OF CORONARY ARTERY DISEASE; PHASE III DATA PRESENTED AT ACC
This article was originally published in The Gray Sheet
Executive Summary
The efficacy of Gensia's GenESA system "appears equivalent to exercise" to perform stress testing in the diagnosis of coronary artery disease, Peter Gardiner, MD, the firm's senior director of clinical research, concluded at a press conference following presentation of Phase III data at the American College of Cardiology scientific sessions on March 15.